Comparison

CD86 Recombinant Protein

€749.00
Excl. VAT
Item no. PRS-96-127-0.2mg
Manufacturer ProSci
Amount 0.2 mg
Category
Type Proteins Recombinant
Format Lyophilized
Applications WB
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias CD86, B7-2, B70, CD28LG2, LAB72, MGC34413
Available
Applications
This recombinant protein can be used for WB. For research use only.
Applications
This recombinant protein can be used for WB. For research use only.
Buffer
Tris with Glycine,  Arginine and NaCl,  pH7.5
Storage Conditions
Lyophilized Protein should be stored at -20˚ C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20˚ C or -70˚ C. Avoid repeated freeze-thaw cycles.
Disclaimer
Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.
Predicted Molecular Weight
51.5 kDa
Purity
>95% as determined by SDS-PAGE.
Background
Cluster of Differentiation 86 (CD86) is also known as B-lymphocyte activation antigen B7-2, is a type I membrane protein that is a member of the immunoglobulin superfamily, and is constitutively expressed on interdigitating dendritic cells, Langerhans cells, peripheral blood dendritic cells, memory B cells, and germinal center B cells. Additionally, B72 is expressed at low levels on monocytes and can be upregulated through interferon γ. CD86 is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD86 works in tandem with CD80 to prime T cells. Recent study has revealed that B7-2 promotes the generation of a mature APC repertoire and promotes APC function and survival. Furthermore, the B7 proteins are also involved in innate immune responses by activating NF-κB-signaling pathway in macrophages. CD86 thus is regarded as a promising candidate for immune therapy. CD86+ macrophages in Hodgkin lymphoma patients are an independent marker for potential nonresponse to firstline-therapy.
1St Image Caption3
The purity of rh CD86 Fc Chimera was determined by DTT-reduced (+) SDS-PAGE and staining overnight with Coomassie Blue.
Background References 1
Chen C, et al., 1994, J. Immunol. 152 (10): 4929–36.
Background References 2
Yadav, D. et al., 2007, J. Immunol. 178: 6236-6241.
Background References 3
Steidl C, et al., 2010, N. Engl. J. Med. 362 (10): 875–85.
Accession #
AAH40261
Ncbi Gene Id #
942
Ncbi Official Symbol
CD86
Ncbi Official Full Name
CD86 molecule
Ncbi Organism
Homo sapiens
Swissprot #
P42081
Fusion Tag
C-Fc Tag
Sequence
Leu 26 - Pro 247
Biological Activity
Measured by its ability to induce IL2 secretion by Jurkat human acute T cell leukemia cells. The ED50 for this effect is typically 0. 04 - 0. 2 ng/ml. Measured by its binding ability in a functional ELISA. Immobilized rhB7-2 / CD86 Fc Chimera at 2μ g/mL (100μ L/well) can bind Biotinylated rh CTLA4, His. Avi Tag with a linear range of 0. 1 - 1μ g/mL.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.2 mg
Available: In stock
Listprice: €749.00
Price: €749.00
available

Delivery expected until 10/2/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close